Noncommunicable Diseases, Rehabilitation and Disability
We are responsible for leading, coordinating and monitoring global action to cover additional people with health services, medicines, vaccines, diagnostic and health technologies for the prevention, screening, early diagnosis and appropriate treatment of cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. We aim to advance health equity for persons with disabilities, we have a focus on sensory impairments and bring together the work on rehabilitation from across the departments and from the 3 levels of the organization.

Chronic respiratory diseases programme

The programme focuses on the 2 most common chronic respiratory diseases (CRDs): asthma and chronic obstructive pulmonary disease (COPD). Approximately half a billion people live with asthma and COPD and together these 2 conditions cause almost 4 million deaths every year. More than 1 million of these deaths occur “prematurely” – in people aged under 70 years. 90% of these premature deaths occur in low- and middle-income countries (LMICs).

Our work is mandated by the WHO Global action plan for the prevention and control of noncommunicable diseases 2013–2030 and the United Nations 2030 Agenda for Sustainable Development.

The main focus of our work in the Management of Noncommunicable Diseases unit is the early diagnosis and appropriate treatment of asthma and COPD, particularly in LMICs.

Diagnosis and management

The WHO package of essential noncommunicable (PEN) disease interventions for primary health care has guidance relating to the acute and long-term management of asthma and COPD in resource-limited settings. The interventions recommended in this guidance are also included in the updated Appendix 3 of the WHO Global NCD Action Plan and the UHC compendium.

Specific to children, the Pocket book of hospital care for children (2013) focuses on acute care at first-referral level in low-resource settings and includes guidance on the management of acute asthma exacerbations.

We are working with colleagues in the Child Health and Development Unit to update the guidelines on the management of asthma in children and adolescents, to include both acute and long term care.

We have also collaborated with colleagues working on rehabilitation to develop a module on COPD for the WHO Package of Interventions for Rehabilitation.

In settings with a high tuberculosis (TB) burden, there are particular challenges in the diagnosis of patients presenting with chronic respiratory symptoms and considerable disability caused by post-TB chronic respiratory disease. Building on the Practical approach to lung health, we are working together with the Global TB programme to raise awareness of these issues and develop pragmatic guidance.

The Department of Noncommunicable Diseases, Rehabilitation and Disability is updating WHO guidance for the diagnosis and management of asthma and COPD in primary care. The guidelines are strongly aligned with WHO’s fourteenth general programme of work (2025–2028), specifically strategic objective 3: advance the primary health care approach and essential health system capacities for universal health coverage.

The guidelines are being developed following the WHO handbook for guideline development. Brief biographies of the proposed Guideline Development Group for asthma can be found here, and for COPD can be found here.

Highlights

Episode #129 - Is pollution causing your COPD?

If you are experiencing breathlessness and fatigue and are exposed to polluted air you could have Chronic Obstructive Pulmonary Disease (COPD). Dr Sarah Rylance explains the symptoms, treatment and prevention of COPD. Find out if you are more susceptible to COPD in Science in 5.
Presented by
Vismita Gupta-Smith

Alternative media

Related links

Transcript

VGS We're standing next to this big no smoking sign in the W.H.O. headquarters. And also we're standing next to a very busy street. Air pollution and smoking. Two of the biggest risk factors for chronic obstructive pulmonary disease. We are going to talk to Doctor Sarah Rylan today about COPD. Sarah, a lot of people may not know what chronic obstructive pulmonary disease or COPD is, even if they may have the disease and may not know how to recognize it. Talk to us about what it is.

SR So COPD is a group of conditions which affect the lungs of adults and cause obstruction of the airways, chronic bronchitis or emphysema or other terms that you might have heard to talk about this. In COPD, we have damage and we have inflammation to different parts of the airways. Depending on which parts are affected, it can affect people differently, and this can lead to different symptoms.

VGS So, Sarah, if people have COPD, how would they know what is actually happening inside us?

SR So the symptoms of COPD come on slowly and often become worse gradually. Someone might notice, for example, that they are having difficulty going about their normal daily life. Sometimes people notice first that they're having difficulty in walking, particularly going up a hill. Or if they have to take the stairs, they may become breathless. As things progress, it might become that they then start to find it difficult to get dressed in the morning, for example, or to do normal daily household chores.

In severe cases, it can become so bad that people are breathless even when they are talking or eating. Sometimes symptoms can become suddenly worse as well. This is called a flare-up or an exacerbation. At that time, people would need to get additional medical treatment. Sometimes they even needed to be admitted to hospital for that. The exact symptoms depend on what is happening inside of the lungs.

So if I have chronic bronchitis, then my airways are inflamed. They're swollen, there's mucus. And so if I have that, then I will be coughing or I'll be coughing up phlegm or mucus. And I might also be breathless. In emphysema, we find that at the end of the airways there are little air sacs, and these can become damaged.

And then air collects in these air sacs, and it means that people can't breathe out fully, so their lungs are overinflated. They have this feeling of their lungs being full all of the time, and it creates a feeling of breathlessness.

VGS Other than smoking and air pollution, what are the causes of COPD?

SR There are lots of different things that can cause COPD. In the past, people really attributed COPD to smoking, and your risk of COPD increases with the more cigarettes that you smoke every day or the longer that you've smoked for. But we now know there are other things too. Air pollution is one that you've mentioned. This could be indoor air pollution.

So exposure through when people are cooking on biomass fuels, for example, like wood or charcoal inside an enclosed space, or outdoor air pollution from traffic or from industry factories, these kinds of things.

VGS Are some people more susceptible to COPD?

SR So actually, yes, our lungs start growing and developing even before we are born, and they continue to grow and develop throughout childhood, throughout teenage years until they reach their maximum potential in your early 20s. If you're exposed to things during that period of lung growth and development that stop your lungs from growing and developing in this way, then this means that you never reach that full potential and you're at increased risk of COPD.

If your mother smokes, or is exposed to air pollution or tobacco smoke during pregnancy. If you're born very small or born early, if you have severe respiratory infections during childhood, all of these things impact your lung growth and development. That means you reach adulthood without having grown your lungs to their full size, if you like.

So you're at more risk of developing COPD. Asthma is another risk factor. If people have asthma in childhood, particularly if it's poorly treated, then that can be a risk factor. There are also some genetic conditions that can predispose to COPD.

VGS That’s actually alarming, that if a mother is breathing air pollution and is a smoker, then the chances of the child developing COPD increases—especially alarming because nine out of ten people are breathing air that's unhealthy for them. Is there a treatment for COPD?

SR If COPD is diagnosed early and appropriate treatment is started promptly, then people with COPD can live as full of a life as possible. Remember, it's not normal to be breathless, and it's not just people who smoke that get COPD. The important things are firstly, stop smoking if people smoke. Secondly, to take regular exercise, and there are special programs called pulmonary rehabilitation for people with COPD to help strengthen their lungs.

Thirdly, there are various inhaled treatments that are available which work in different ways inside the lungs that can be helpful. Lastly, it's very important to protect from infection. So if someone has COPD, it's really important that they get vaccinated against flu and Covid, for example, other respiratory infections.

VGS Thank you, Sarah. That was science and five today. Until next time then, stay safe, stay healthy, and stick with science.

Speaker key

  • SR Sarah Rylance
  • VGS Vismita Gupta-Smith

Related publications

Package of interventions for rehabilitation: module 4: cardiopulmonary conditions

The Package of interventions for rehabilitation outlines the most essential interventions for rehabilitation for 20 health conditions. For each of...

Framework for collaborative action on tuberculosis and comorbidities

Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred...

WHO package of essential noncommunicable (PEN) disease interventions for primary health care

Noncommunicable diseases (NCDs), also known as chronic diseases, tend to be of long duration and are the result of a combination of genetic, physiological,...

Global action plan for the prevention and control of noncommunicable diseases 2013-2020

The WHO Global NCD action plan 2013–2020 follows on from commitments made by Heads of State and Government in the United Nations Political Declaration...

Pocket book of hospital care for children: Second edition

This is the second edition of the Pocket book of hospital care for children. It is for use by doctors, nurses and other health workers who are responsible...

Practical approach to lung health : manual initiating PAL implementation

The Practical Approach to Lung Health (PAL) is one of the strategies intended to overcome the challenge posed by weak health systems. This initiative is...

Access to essential technology and medicines

The WHO NCD Global Action Plan includes the target of 80% availability of the affordable basic technologies and essential medicines, required to treat major NCDs in both public and private facilities.

However, data collected through the NCD country capacity survey reveals that for low- and low-middle-income countries:

  • peak flow meters, the most basic technology included in PEN, are available in 25% of countries
  • bronchodilator inhalers, potentially lifesaving emergency treatment, are available in 60% of countries
  • steroid inhalers, an essential part of long term asthma treatment, are available in 40% of countries.


We are working to understand the barriers and potential solutions to address this.

 

Related links

Integration of prevention and control

An integrated approach, including both the prevention and management of asthma and COPD, is required to make progress towards SDG target 3.4 "By 2030, reduce by one third premature mortality from NCDs, through prevention and treatment".

Air pollution

Air pollution (indoor and outdoor) is associated with the development and worsening of CRDs, and improving air quality can result in respiratory health gains. We are collaborating with the Air Quality and Health Unit to develop tools and training for health care providers to help limit the impact of air pollution on people living with chronic respiratory diseases.

Air pollution and health training toolkit for health workers

Tobacco

Exposure to tobacco smoke is a risk factor for the development of asthma and COPD, and for worsening of existing disease. Smoking cessation has the greatest capacity to influence the lung function decline experienced in COPD. We are working together with the Tobacco Free Initiative to create Tobacco Knowledge Summaries for asthma and COPD, building on previous advocacy publications.

Don't let tobacco take your breath away: choose health, not tobacco, 31 May, World Tobacco Day

New tobacco and asthma knowledge summary

Surveillance, monitoring and reporting

Data on CRDs is essential to assist policy-makers and managers in health systems planning, delivery, monitoring, and evaluation. Recently developed asthma and COPD indicators, published in the Noncommunicable disease facility-based monitoring guidance: framework, indicators and application, are now being integrated into the DHIS2 (District Health Information Software 2) NCD package.

Data on CRD risk factors is collected through several WHO surveys and presented in the NCD data portal.

The Global Health Observatory also hosts the air pollution data portal.

 

Global leadership

The Global Alliance against Chronic Respiratory Diseases (GARD) is a WHO-convened global network of stakeholders with a vision of “a world where all people breathe freely”.

Members of the GARD network are committed to reduce the global burden of chronic respiratory diseases (CRDs), focusing on LMICs. Through advocacy and collaborative networking, members are working to ensure all people with asthma and COPD receive a timely diagnosis and can access effective care, and to reduce exposure to risk factors such as tobacco smoke and air pollution.

 

Related health topics

Related fact sheets

Feature stories